Evidence map›Paper›PMID 41334652›Full record

ArticleJournal of basic microbiology2026

Mycobacteriophage Mcgavigan Uses Noncanonical Bxb1-Like Repressor for Heterotypic Superinfection Immunity.

Natali Shafer, Bradley E Dubrule, Jeroen De Buck

Abstract read
In one paragraph

Article in Journal of basic microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Natali ShaferFaculty of Veterinary Medicine, University of Calgary, Calgary, Alberta, Canada.ORCID https://orcid.org/0009-0009-6534-4879
Bradley E DubruleFaculty of Veterinary Medicine, University of Calgary, Calgary, Alberta, Canada.ORCID https://orcid.org/0000-0002-0266-0075
Jeroen De BuckFaculty of Veterinary Medicine, University of Calgary, Calgary, Alberta, Canada.ORCID https://orcid.org/0000-0002-4824-9580

Funding

This study was supported by a grant from Agriculture Funding Consortium (2024F2352R), supported by Research Driven Agricultural Research (RDAR), Sustainable Canadian Agricultural Partnership (SCAP) and Alberta Milk.
6 · The paper itself

Abstract

Mycobacteriophage Mcgavigan could be a promising candidate for use as a preventative agent against infections with Mycobacterium avium subsp. paratuberculosis. Bioinformatic analysis of the Mcgavigan genome revealed the presence of an operon containing a "Bxb1-like" repressor. The operon may have been acquired by the phage through horizontal gene transfer with a Bxb1-like mycobacteriophage in its evolutionary past. We sought to investigate the function of the acquired repressor as a potential regulator of lysogeny or as a source of heterotypic superinfection immunity. Recombineering with CRISPR counter-selection was employed to achieve a clean deletion of the Bxb1-like repressor from Mcgavigan's genome. Integrase was also deleted as a means of creating a lytic-only phage for comparison purposes and the elimination of lysogeny with this edit was confirmed. To test phenotypic changes which resulted from these deletions, several parameters such as burst size, latency period, and killing efficiency were measured for each knockout mutant and lysogeny was tested. The integrase deletion mutant had complete lysogeny abolishment and performed similarly to wild-type phage on all measured parameters. The deletion of the Bxb1-like repressor did not affect the lysogenic capability of the phage. Whereas Mcgavigan lysogens are typically immune to superinfection from Terelak, a mycobacteriophage related to Bxb1, lysogens created from Mcgavigan with the Bxb1-like repressor deletion were completely resensitized to heterotypic superinfection by Terelak. This suggested that this repressor was acquired by Mcgavigan through horizontal gene transfer for the purposes of superinfection immunity against cluster A1 mycobacteriophages and was not used for maintenance of lysogeny.

Indexed as

MycobacteriophagesRepressor ProteinsSuperinfectionGene Transfer, HorizontalGenome, ViralIntegrasesLysogenyMycobacterium aviumOperonIntegrasesRepressor ProteinsJohne's diseaselysogenymycobacteriophagerecombineeringsuperinfection immunity

Identifiers

PMID41334652
PMCPMC12700041

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.